HIV news from aidsmap.com

Worse HIV control at diagnosis doesn't mean worse lymphoma outcomes
The outcomes of lymphoma – one of the most common types of cancer in people with HIV – seem to be largely uninfluenced by viral suppression at the time of diagnosis. Although people with detectable viral load had lower CD4 counts and more advanced lymphoma when diagnosed, their chances of remission and survival were similar to those of people whose HIV was suppressed.
>> Read more

Switching to an integrase inhibitor can raise diabetes risk in people with HIV
Two large studies have found that switching to an integrase inhibitor carries a moderately increased risk of developing type 2 diabetes for some groups of people with HIV. In one study, which combined data from 27 cohorts of people receiving HIV care in North America, switching from a protease inhibitor to an integrase inhibitor increased the risk of developing type 2 diabetes within two years. Switching from a non-nucleoside reverse transcriptase inhibitor to an integrase inhibitor did not raise the risk of developing diabetes.
>> Read more

Bepirovirsen leads to functional cure in one fifth of people with long-term hepatitis B
One in five people with chronic (long term) hepatitis B who were treated with the investigational agent bepirovirsen were functionally cured and no longer needed to take daily antiviral therapy, according to late-stage study results presented last week at the European Association for the Study of the Liver (EASL) Congress in Barcelona and published in The New England Journal of Medicine.
>> Read more